Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis.
about
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in CancerThe Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1Diagnostic utility of galectin-3 in thyroid cancer.Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment.A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancerReprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.When galectins recognize glycans: from biochemistry to physiology and back againChemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis.Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.Do galectins play a role in venous thrombosis? a review.Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3.Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering.Glycodendrimers: tools to explore multivalent galectin-1 interactionsProteomics of microparticles after deep venous thrombosis.Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling.
P2860
Q26744538-1B3CF035-93DF-4178-BACE-71DC6E90E48FQ28075523-6D0D4090-5D57-4CA4-A2BF-BBFCC45DAD31Q33816239-DB6DA591-9C8A-4589-AB64-B56F68CFB750Q34545405-B943C5DD-9D92-49FB-BD75-E9CA65E731ABQ34721103-348354E2-E23B-45B2-A69C-F3BCCEAA9436Q35799094-D2C196A4-7928-4D0C-B7E2-EE5228788248Q35931701-83E5C568-8A1E-4C95-A0DE-7E46D31BE939Q36196146-04569EC4-31F1-446F-9B5D-12AE24C4BCA5Q36414261-D3B428A3-3164-479F-9312-F00D8C969EADQ37406706-978D9366-65FB-4DFC-A600-57A2B183392CQ37644081-083E8671-F72E-40E9-B3D4-182257899931Q37701353-B1F5CB44-F2E1-4940-BDC1-93B2433E976EQ38297428-55582948-8809-4106-A539-4F06E17BD908Q38777463-5DA2268F-E105-4E46-99D8-1509FE6E8F0AQ41925209-52816C7D-DF0C-4C41-8104-845C3F43F604Q42455347-F4BD3E26-DC24-4798-B3A7-B34ABBFDCD70Q48159532-4632AA1F-2BCC-4E63-8076-CADFFE3BA553
P2860
Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Synthetic inhibitors of galect ...... tion and tumor cell apoptosis.
@en
type
label
Synthetic inhibitors of galect ...... tion and tumor cell apoptosis.
@en
prefLabel
Synthetic inhibitors of galect ...... tion and tumor cell apoptosis.
@en
P2093
P1433
P1476
Synthetic inhibitors of galect ...... ation and tumor cell apoptosis
@en
P2093
Albana Cumashi
Andrei A Sherman
Clara Natoli
Consorzio Interuniversitario Nazionale Per la Bio-Oncologia
Enza Piccolo
Gabriel A Rabinovich
Ida Iurisci
Maurizia D'Egidio
Nicola Tinari
Nikolay E Nifantiev
P304
P407
P577
2009-01-01T00:00:00Z